DWM
XBIO icon

Darwin Wealth Management’s Xenetic Biosciences XBIO Stock Holding History

Darwin Wealth Management’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Hold
2
– – ﹤0.01% 761
2026
Q1 		$5 Hold
2
– – ﹤0.01% 601
2025
Q4 		$4 Hold
2
– – ﹤0.01% 658
2025
Q3 		$6 Hold
2
– – ﹤0.01% 604
2025
Q2 		$7 Hold
2
– – ﹤0.01% 605
2025
Q1 		$7 Hold
2
– – ﹤0.01% 637
2024
Q4 		$7 Hold
2
– – ﹤0.01% 637
2024
Q3 		$9 Buy
+2
New +$8 ﹤0.01% 645
2020
Q2 		– Sell
-1
Closed – – 804
2020
Q1 		$0 Buy
+1
New +$12 ﹤0.01% 862

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Darwin Wealth Management's XBIO Position: Q2 2026 in Review

Darwin Wealth Management held its Xenetic Biosciences (XBIO) position steady in Q2 2026 at 2 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Darwin Wealth Management first reported a position in XBIO in Q1 2020 and has held it in 9 quarters since. The position peaked at $9 in Q3 2024. 8 funds tracked by Wall St. Rank hold XBIO as of Q2 2026.

  • Darwin Wealth Management held 2 shares of Xenetic Biosciences worth $5 as of Q2 2026.
  • Darwin Wealth Management left its Xenetic Biosciences share count unchanged in Q2 2026.
  • Xenetic Biosciences made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #761 holding.
  • Darwin Wealth Management first reported a position in Xenetic Biosciences in Q1 2020 and has held it in 9 quarters since.
  • Darwin Wealth Management's Xenetic Biosciences position peaked at $9 in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.